Remove 2015 Remove Competition Remove Leads
article thumbnail

Pharma is big business whose goal is to maximize shareholder value

World of DTC Marketing

From 2016 to 2020, the 14 leading drug companies spent $577 billion on stock buybacks and dividends—$56 billion more than they spent on R&D over the same period.” In a 2015 study of 36 cancer drugs that had recently been approved, only 5 showed extended life. Big pharma is big business. Here’s another example.

Pharma 292
article thumbnail

Is the launch environment really more competitive now?

pharmaphorum

It’s often stated – mostly without reference to data – that the environment for innovative launches is more competitive now than it ever has been. A second, “transitional era” from 2000-2015 was one of older specialty products, including those in multiple sclerosis, early immunological biologics, and oncologics.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Takeda plans 2026 CEO succession

European Pharmaceutical Review

Weber was subsequently appointed as CEO in April 2015, the company shared. Now is the right time to appoint my successor given our competitive growth outlook, new product launches expected from the second half of 2026 onwards and the anticipated retirement of some external independent directors in the coming years, explained Weber.

article thumbnail

Harnessing the Power of Generational Diversity as a Competitive Advantage

PM360

Today’s workforce includes Traditionalists (born 1927-1945), Boomers (1946-1964), Gen X (1965-1980), Millennials (1981-1996), and Gen Z (1997-2015). Marketing and comms teams that go beyond simply accepting generational differences by leveraging them proactively will lead to increased engagement, innovation, and organizational success.

article thumbnail

Sales Retention: Will You Be Able to Keep Your Superstars In The Future?

Integrity Solutions

Today, amid market volatility, changing customer expectations and heightened competition, it’s more important than ever. employees are either watching for or actively seeking a new job — the highest level since 2015. Especially in a tight job market, talented salespeople are one of your biggest competitive differentiators.

Sales 171
article thumbnail

2020 Sales Hiring Forecast

Sales Talent

As there isn’t a hiring forecast specific for b2b sales roles, we started our own forecast in 2015 to help fill this gap. This pressure is leading to increased base salaries. It also means that employers face the most competitive, candidate-driven employment market in history. 2019 Sales Hiring in Review.

Sales 130
article thumbnail

Understanding the evidence used in drug product withdrawals

European Pharmaceutical Review

Observational studies should not be seen as competition to RCTs but as complementary to them, and as a sector we need to stop working in silos and develop an integrated and more comprehensive approach to evidence-based decision-making in safeguarding public health. Guide on Methodological Standards in Pharmacoepidemiology (Revision 11).

Medicine 116